Raleigh, NC, United States of America

Martin Osterhout

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2003-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Martin Osterhout

Introduction

Martin Osterhout, an accomplished inventor based in Raleigh, NC, has made significant contributions to the fields of pharmacology and therapeutics. With a total of four patents to his name, his work primarily focuses on developing innovative solutions for managing metabolic disorders, particularly diabetes.

Latest Patents

Osterhout's latest patents showcase his expertise in creating novel therapeutic agents. His first notable patent involves glucagon receptor antagonists, which includes solid state forms of compounds that exhibit enantiomerically pure forms and pharmaceutically acceptable salts or co-crystals. This innovative approach presents methods for treating, preventing, or ameliorating conditions associated with Type I and II diabetes, among others. The second patent details the inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas. This invention opens new avenues for treating cytokine-mediated diseases and proteolytic enzyme-mediated diseases, along with the corresponding pharmaceutical compositions designed for such therapeutic applications.

Career Highlights

Throughout his career, Martin Osterhout has held positions at prominent pharmaceutical companies, notably SmithKline Beecham Corporation and Bayer Pharmaceuticals Corporation. His work in these organizations has enhanced his practical knowledge and allowed him to develop groundbreaking innovations that benefit numerous patients.

Collaborations

Collaboration has been a vital aspect of Osterhout's journey, allowing him to work alongside talented individuals in the industry. Among his notable coworkers are Susan Mary Daluge and Michael Tolar Martin, with whom he has shared insights, knowledge, and expertise, contributing to their collective advancements in the pharmaceutical field.

Conclusion

Martin Osterhout's relentless pursuit of innovation in the pharmaceutical arena has made significant strides in the management of diabetes and related conditions. His patents reflect a deep understanding of metabolic diseases and a commitment to improving patients' lives through advanced therapeutic solutions. As he continues his work, the impact of his inventions is sure to resonate within the scientific community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…